BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 29110281)

  • 1. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
    J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
    Jamilian M; Foroozanfard F; Rahmani E; Talebi M; Bahmani F; Asemi Z
    Nutrients; 2017 Nov; 9(12):. PubMed ID: 29186759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial.
    Al-Bayyari N; Al-Domi H; Zayed F; Hailat R; Eaton A
    Clin Nutr; 2021 Mar; 40(3):870-878. PubMed ID: 33010974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Tabrizi FPF; Farhangi MA; Vaezi M; Hemmati S
    Nutr J; 2020 Aug; 19(1):82. PubMed ID: 32782010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
    Azadi-Yazdi M; Karimi-Zarchi M; Salehi-Abargouei A; Fallahzadeh H; Nadjarzadeh A
    J Hum Nutr Diet; 2017 Jun; 30(3):275-283. PubMed ID: 28466507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
    Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a low-calorie diet or an isocaloric diet combined with metformin on sex hormones In obese women of child-bearing age.
    Swora-Cwynar E; Kujawska-Łuczak M; Suliburska J; Reguła J; Kargulewicz A; Kręgielska-Narożna M; Marcinkowska E; Kanikowska A; Bielas M; Grzymisławski M; Bogdański P
    Acta Sci Pol Technol Aliment; 2016; 15(2):213-220. PubMed ID: 28071011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Razavi M; Jamilian M; Karamali M; Bahmani F; Aghadavod E; Asemi Z
    Horm Metab Res; 2016 Jul; 48(7):446-51. PubMed ID: 27050252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome.
    Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Talaee R; Jafarnejad S; Hashemi Dizaji S; Asemi Z
    J Affect Disord; 2018 Oct; 238():32-38. PubMed ID: 29859385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin D supplementation on anthropometric indices among overweight and obese women: A double blind randomized controlled clinical trial.
    Roosta S; Kharadmand M; Teymoori F; Birjandi M; Adine A; Falahi E
    Diabetes Metab Syndr; 2018 Jul; 12(4):537-541. PubMed ID: 29615318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
    Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
    Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome.
    Izadi A; Ebrahimi S; Shirazi S; Taghizadeh S; Parizad M; Farzadi L; Gargari BP
    J Clin Endocrinol Metab; 2019 Feb; 104(2):319-327. PubMed ID: 30202998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
    Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
    Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Maktabi M; Chamani M; Asemi Z
    Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR; Gargari BP; Farzadi L
    Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.